A 6 MODULE SELF-MANAGED DISTANCE LEARNING COURSE – An insider’s guide to the pharmaceutical industry for anyone new who wants to enhance their knowledge on working in the pharma, bio-tech or life sciences sectors. Gain key skills needed with this 6 module course requiring 3 to 4 hours study each module.
To find out how our unique Learning Management System delivers our on-line training programmes and how easy to use and interactive they are click HERE
To find out how to register, access and complete your online distance learning programme click HERE
Falconbury’s expert speaker and course contributor John Ansell gives his view on the latest developments within the pharmaceutical industry.
Participants are invited to undertake a final assessment in the form of an online multiple-choice paper. A pass rate of 80% and above is required to ensure that a high level of competency has been achieved within the subject area, where upon you will receive a ‘Certificate of Excellence’.
Understanding the dynamics and drivers of the industry YOU work in is key to understanding how and why key decisions are made within your organisation.
In turn, this enables you to appreciate your potential impact on the overall success of the organisation. With this in mind, Falconbury have developed this on-line course which delivers a complete insider’s guide to the pharmaceutical industry; it’s history and background, the process of discovery, clinical trials, taking the drug to market; the challenges and opportunities facing the industry now and in the future.
If you are new to the industry, or are in a support role or otherwise would like to broaden your understanding of the environment in which you work, then this 6 module course is essential for your development.
Anyone working within the industry who is new to it or who would like to broaden their understanding of the pharmaceutical industry and who works in any of the following functions:
Since 1989 John Ansell has been a pharmaceutical industry consultant. He concentrates on international projects with a commercial and strategic emphasis, reflecting his previous industry experience in marketing and business development. He has worked with many major pharmaceutical companies but advises companies of all sizes including start-ups, as well as those providing services to the industry and those investing in it: some 110 clients in all.
A Biochemistry graduate with a Masters degree in Business Studies, John started his 20-year career in the pharmaceutical industry in Holland with Organon. He subsequently worked for Schering AG and Fisons in the UK, and again in Holland, with Solvay. Lastly, from 1985 to 1989 he worked in international marketing for Glaxo Holdings.
He is the author of over 40 articles and reports on pharmaceutical issues. His most recent article is Product Life Spans: Trends in the Quality and Staying Power of New Products(Spectrum, Decision Resources, June 2008).
He has advised numerous investment banks including six of the top seven; he is placed in the top 5% Leader category of the Gerson Lehrman Group’s consultants, based on quality of interaction with its financial and consultancy clients. He is also Honorary Consultant to the University of Manchester School of Pharmacy and Pharmaceutical Sciences.
John is a frequent speaker at industry conferences on various aspects of deals, marketing and R & D strategy. He has presented on US and European biotech deals, on deals involving genomics, generics and OTC, as well as widely on mergers and alliances. He has also acted as chairman at well over 30 pharmaceutical conferences, on a wide range of topics including biotechnology, R & D, business development and licensing, technology transfer, due diligence, marketing, promotion, pricing and corporate governance.
John was a long-standing member of the Editorial Advisory Board of the US journal Pharmaceutical Executive (1990-2002), served on the Editorial Board of the Journal of Biotechnology in Healthcare (1994-98), and has been Chairman of the Advisory Board of Decision Resources since its inception in 2005.
The International Association for Distance Learning (IADL) promotes excellence in open, distance, and online learning worldwide, and provides a benchmark through which global consumers can gauge the quality of courses offered by their members.
The IADL is an independent, non-profit organisation with its principal administrative offices in London in the United Kingdom. Find out more.
Falconbury are an Approved Member of the International Association for Distance Learning.
|Understanding the Pharmaceutical Industry|
|MODULE 1 - Introduction to the Prescription Pharmaceutical Industry|
|MODULE 2 - Drug Discovery and Development - Part 1|
|MODULE 3 - Drug Discovery and Development - Part 2|
|MODULE 4 - Commercial Functions - Part 1: Business Development and Pricing|
|MODULE 5 - Commercial Functions - Part 2: Marketing, Sales and Distribution|
|MODULE 6 - Current and Future Trends|